日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/11/19 | 3,530 | 3,659 | 3,530 | 3,620 | +95 | +2.7% | 547,300 |
| 2025/11/18 | 3,552 | 3,635 | 3,508 | 3,525 | -21 | -0.6% | 328,500 |
| 2025/11/17 | 3,558 | 3,572 | 3,477 | 3,546 | -8 | -0.2% | 372,200 |
| 2025/11/14 | 3,361 | 3,637 | 3,332 | 3,554 | +197 | +5.9% | 674,300 |
| 2025/11/13 | 3,364 | 3,400 | 3,354 | 3,357 | +17 | +0.5% | 225,000 |
| 2025/11/12 | 3,327 | 3,364 | 3,316 | 3,340 | +36 | +1.1% | 182,800 |
| 2025/11/11 | 3,275 | 3,308 | 3,263 | 3,304 | +43 | +1.3% | 213,400 |
| 2025/11/10 | 3,290 | 3,290 | 3,261 | 3,261 | -18 | -0.5% | 168,500 |
| 2025/11/07 | 3,251 | 3,286 | 3,247 | 3,279 | +52 | +1.6% | 185,800 |
| 2025/11/06 | 3,245 | 3,258 | 3,227 | 3,227 | -21 | -0.6% | 170,400 |
| 2025/11/05 | 3,270 | 3,290 | 3,203 | 3,248 | -22 | -0.7% | 214,500 |
| 2025/11/04 | 3,252 | 3,282 | 3,219 | 3,270 | +49 | +1.5% | 293,700 |
| 2025/10/31 | 3,272 | 3,277 | 3,221 | 3,221 | -50 | -1.5% | 272,200 |
| 2025/10/30 | 3,210 | 3,276 | 3,205 | 3,271 | +54 | +1.7% | 415,400 |
| 2025/10/29 | 3,300 | 3,306 | 3,212 | 3,217 | -96 | -2.9% | 261,700 |
| 2025/10/28 | 3,325 | 3,333 | 3,292 | 3,313 | -23 | -0.7% | 174,000 |
| 2025/10/27 | 3,349 | 3,363 | 3,327 | 3,336 | +15 | +0.5% | 199,100 |
| 2025/10/24 | 3,362 | 3,370 | 3,318 | 3,321 | -61 | -1.8% | 124,700 |
| 2025/10/23 | 3,388 | 3,414 | 3,363 | 3,382 | +13 | +0.4% | 324,300 |
| 2025/10/22 | 3,318 | 3,380 | 3,318 | 3,369 | +78 | +2.4% | 380,700 |
| 2025/10/21 | 3,286 | 3,305 | 3,285 | 3,291 | +1 | ±0% | 105,300 |
| 2025/10/20 | 3,300 | 3,316 | 3,282 | 3,290 | +41 | +1.3% | 203,300 |
| 2025/10/17 | 3,258 | 3,263 | 3,241 | 3,249 | -9 | -0.3% | 127,500 |
| 2025/10/16 | 3,262 | 3,270 | 3,247 | 3,258 | +12 | +0.4% | 102,400 |
| 2025/10/15 | 3,244 | 3,256 | 3,225 | 3,246 | +33 | +1% | 179,300 |
| 2025/10/14 | 3,220 | 3,253 | 3,187 | 3,213 | -71 | -2.2% | 465,300 |
| 2025/10/10 | 3,346 | 3,352 | 3,284 | 3,284 | -103 | -3% | 239,200 |
| 2025/10/09 | 3,305 | 3,387 | 3,300 | 3,387 | +73 | +2.2% | 318,200 |
| 2025/10/08 | 3,316 | 3,341 | 3,307 | 3,314 | -2 | -0.1% | 186,000 |
| 2025/10/07 | 3,310 | 3,345 | 3,297 | 3,316 | -14 | -0.4% | 233,800 |
| 2025/10/06 | 3,330 | 3,365 | 3,311 | 3,330 | +34 | +1% | 336,700 |
| 2025/10/03 | 3,300 | 3,314 | 3,285 | 3,296 | +3 | +0.1% | 289,600 |
| 2025/10/02 | 3,290 | 3,305 | 3,240 | 3,293 | +31 | +1% | 221,100 |
| 2025/10/01 | 3,333 | 3,342 | 3,262 | 3,262 | -71 | -2.1% | 285,300 |
| 2025/09/30 | 3,270 | 3,339 | 3,265 | 3,333 | +68 | +2.1% | 344,500 |
| 2025/09/29 | 3,319 | 3,320 | 3,262 | 3,265 | -102 | -3% | 315,300 |
| 2025/09/26 | 3,339 | 3,409 | 3,320 | 3,367 | +58 | +1.8% | 497,300 |
| 2025/09/25 | 3,320 | 3,328 | 3,303 | 3,309 | -5 | -0.2% | 262,400 |
| 2025/09/24 | 3,340 | 3,340 | 3,306 | 3,314 | -5 | -0.2% | 320,000 |
| 2025/09/22 | 3,329 | 3,332 | 3,302 | 3,319 | -23 | -0.7% | 277,900 |
| 2025/09/19 | 3,390 | 3,408 | 3,330 | 3,342 | +32 | +1% | 722,300 |
| 2025/09/18 | 3,331 | 3,340 | 3,301 | 3,310 | +11 | +0.3% | 181,000 |
| 2025/09/17 | 3,330 | 3,350 | 3,299 | 3,299 | -40 | -1.2% | 236,500 |
| 2025/09/16 | 3,290 | 3,348 | 3,284 | 3,339 | +46 | +1.4% | 218,400 |
| 2025/09/12 | 3,302 | 3,310 | 3,277 | 3,293 | -4 | -0.1% | 210,500 |
| 2025/09/11 | 3,295 | 3,310 | 3,271 | 3,297 | -2 | -0.1% | 192,900 |
| 2025/09/10 | 3,302 | 3,321 | 3,289 | 3,299 | -3 | -0.1% | 175,000 |
| 2025/09/09 | 3,368 | 3,386 | 3,302 | 3,302 | -78 | -2.3% | 290,000 |
| 2025/09/08 | 3,328 | 3,384 | 3,307 | 3,380 | +86 | +2.6% | 332,400 |
| 2025/09/05 | 3,260 | 3,301 | 3,250 | 3,294 | +24 | +0.7% | 307,900 |
151～
200
件表示中 / 3977件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 413,600円 | +17.1% | +5.9% | 3.00% | 9.20倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 154,950円 | +19.1% | -10.3% | 0.00% | 9.03倍 | 2.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 239,800円 | +7.5% | -3.9% | 2.09% | 15.71倍 | 1.79倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 379,800円 | +10.9% | -11.3% | 4.16% | 10.80倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 419,500円 | +11.1% | +6.8% | 2.03% | 9.61倍 | 1.15倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
